Abstract
In cases of severe hyperlipidemia, we have very effective therapeutic tools nowadays. LDL-apheresis is still the most effective therapy for familial hypercholesterolemia, especially in its homocygous form. In combination with statins, LDL-cholesterol can be lowered by 80%. Most other genetic and secondary hyperlipidemias can effectively be treated by lipid lowering drugs. This aggressive treatment gains more and more on importance in view of the tough recommendations of specific scientific societies. Atorvastatin and simvastatin can lower LDL-cholesterol by 60%. In this report different therapies and combination therapies for hyperlipidemia are discussed.
MeSH terms
-
Anticholesteremic Agents / adverse effects
-
Anticholesteremic Agents / therapeutic use*
-
Atorvastatin
-
Blood Component Removal
-
Cholesterol, LDL / blood
-
Combined Modality Therapy
-
Coronary Artery Disease / blood
-
Coronary Artery Disease / drug therapy*
-
Heptanoic Acids / adverse effects
-
Heptanoic Acids / therapeutic use
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Hypercholesterolemia / blood
-
Hypercholesterolemia / drug therapy*
-
Pyrroles / adverse effects
-
Pyrroles / therapeutic use
-
Simvastatin / adverse effects
-
Simvastatin / therapeutic use
Substances
-
Anticholesteremic Agents
-
Cholesterol, LDL
-
Heptanoic Acids
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Pyrroles
-
Atorvastatin
-
Simvastatin